JLK Inc (322510.KQ) stock: key figures, P/E, revenue and dividend

Information Technology · Application Software · South Korea · ISIN KR7322510009

Price
4,535.00 KRW
Market cap
114.23 bn KRW
P/E (2025)
–
P/S (2025)
34.21
Dividend yield
0.00 %
Net margin
-407.43 %
Return on equity (ROE)
-32.90 %
Return on assets (ROA)
-18.28 %

JLK Inc financials

Fiscal year20242025
Revenue1.43 bn KRW3.34 bn KRW
Gross profit-6.45 bn KRW3.34 bn KRW
Operating income-12.73 bn KRW-13.20 bn KRW
EBIT-12.34 bn KRW-12.13 bn KRW
Net income-13.45 bn KRW-13.61 bn KRW
Diluted EPS – continuing operations-533.94 KRW-540.16 KRW

Full history since 2017, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About JLK Inc

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology. JLK, Inc. was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. was incorporated in 2014 and is based in Cheongju-si, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.